This paper is only available as a PDF. To read, Please Download here.
- 1.1. The results of treatment of sixty-five hypertensive patients with 1-hydrazinophthalazine are presented.
- 2.2. Patients with essential hypertension or malignant hypertension responded favorably.
- 3.3. Patients with hypertension of the “renal” type showed an insignificant response.
- 4.4. Postsympathectomy patients with persistent hypertension had variable responses and judgment as to the value of the drug must be delayed until more cases are studied.
- 5.5. Undesirable side effects caused ten patients to discontinue the drug.
- 6.6. The pharmacology of 1-hydrazinophthalazine is discussed.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of Medicine
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- A new group of depressor substances with a special type of effect.Experientia. 1950; 6: 19
- Renal hyperemia induced in man by a new phthalazine derivative.in: 3rd ed. Proc. Soc. Exper. Biol. & Med.73. 1950: 102
- Some pharmacodynamic effects of 1-hydrazinophthalazine (C-5968) with particular reference to renal function and cardiovascular response.J. Pharmacol. & Exper. Therap. 1951; 103: 368
- Effects of 1-hydrazinophthalazine in hypertension.Circulation. 1952; 5: 28
- Treatment of essential and malignant hypertension.J. A. M. A. 1951; 147: 1311
- The treatment of hypertension with hexamethonium.Circulation. 1952; 5: 20
- Control of hypertension by hexamethonium and 1-hydrazinophthalazine.Arch. Int. Med. 1952; 89: 523
- The effect of “sympatholytic” drugs on the cardiovascular responses to epinephrine and norepinephrine in man.Circulation. 1951; 3: 254
- Control of hypertension by hexamethonium and 1-hydrazinophthalazine.Arch. Int. Med. 1952; 89 (Cited by Schroeder): 523
- A hormonal neurogenic vasopressor mechanism.Arch. Int. Med. 1951; 88: 1
- Control of hypertension by hexamethonium and 1-hydrazinophthalazine.Arch. Int. Med. 1952; 89 (Personal observations): 523
- Effect of 1-hydrazinophthalazine (C-5968) on cardiovascular system of unanesthetized dogs.in: 3rd ed. Federation Proc.9. 1950: 323
- Effects on hypertension of sulfhydryl and hydrazine compounds.J. Clin. Investigation. 1951; 30: 672
- A hormonal neurogenic vasopressor mechanism.Arch. Int. Med. 1951; 88 (Unpublished observations, cited by Taylor): 1
Kory, R. C., Roehm, D. C. and Meneely, G. R. The ballistocardiographic response to “depressor” drugs. Proc. Am. Federation Clin. Research, Am. J. Med., in press.
- Some pharmacological properties of 1-hydrazinophthalazine, a hypotensive agent.in: 3rd ed. Federation Proc.9. 1950: 265
☆Supported in part by the Middle Tennessee Heart Association and Ciba Pharmaceutical Products, Inc.
© 1953 Published by Elsevier Inc.